Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Capital Employed (2022 - 2026)

HeartSciences' Return on Capital Employed history spans 5 years, with the latest figure at 3.11% for Q1 2026.

  • For Q1 2026, Return on Capital Employed fell 49.0% year-over-year to 3.11%; the TTM value through Jan 2026 reached 3.11%, down 49.0%, while the annual FY2025 figure was 2.64%, 129.0% down from the prior year.
  • Return on Capital Employed reached 3.11% in Q1 2026 per HSCS's latest filing, down from 1.77% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 5.54% in Q4 2023 to a low of 6.63% in Q2 2025.
  • Average Return on Capital Employed over 5 years is 2.32%, with a median of 2.62% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 864bps in 2023, then crashed -714bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 3.09% in 2022, then surged by 279bps to 5.54% in 2023, then plummeted by -129bps to 1.59% in 2024, then fell by -11bps to 1.77% in 2025, then crashed by -76bps to 3.11% in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Return on Capital Employed are 3.11% (Q1 2026), 1.77% (Q4 2025), and 3.52% (Q3 2025).